Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
94,179,674
-
Total 13F shares
-
20,679,259
-
Share change
-
+3,151,685
-
Total reported value
-
$303,859,789
-
Price per share
-
$14.70
-
Number of holders
-
54
-
Value change
-
+$45,414,739
-
Number of buys
-
19
-
Number of sells
-
27
Institutional Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q1 2020
As of 31 Mar 2020 Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) had 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 20,679,259 shares of stock of the company.
Largest 10 holders included FMR LLC, Vivo Capital, LLC, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, BlackRock Inc., VANGUARD GROUP INC, and JANUS HENDERSON GROUP PLC.
This table shows 54 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.